Nicola Maguire

    • Immunocore $312.1 Million Aggregate Financing 

    • Cooley Advises CEPI on its Partnership with VBI Vaccines Inc., to Develop VBI’s Vaccine Candidates Against Covid-19 Variants 

    • Immunocore – $297 Million IPO 

    • Genesis MedTech Acquires Drug Device Asset From TriReme Medical 

    • UNION Therapeutics Enters Licensing Option Agreement with TFF Pharmaceuticals 

    • Bavarian Nordic Acquires Two Commercial Vaccines from GlaxoSmithKline for €796 Million 

    • Mission Therapeutics Enters Collaboration Agreement with AbbVie 

    • Cooley Advises F-star on Collaborative Agreement with Denali Therapeutics 

    • Bristol Meyers Enters Agreement with Five Prime 

    • Immunocore Limited Series A $320 Million Financing 

    • Cooley Advises Immunocore on Largest European Private Life Sciences Financing on Record 

    • King's College Collaboration and Licence Agreement with UCB 

    • Meda: Rottapharm l Madaus Acquisition  

    • Wellcome Trust Collaboration and Option Agreement with Jansen and University of Leuven 

    • Karolinska Development Joint Venture with Rosetta Capital